News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McClellan William D. Jr.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 6,017 shares
@ $0
Disposed/sold 6,300 options to buy
@ $130.92, valued at
$824.8k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 99 options to buy
@ $27.32, valued at
$2.7k
Disposed/sold 416 options to buy
@ $34.76, valued at
$14.5k
Disposed/sold 5,620 options to buy
@ $34.76, valued at
$195.4k
Disposed/sold 135 options to buy
@ $93.61, valued at
$12.6k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
Disposed/sold 4,500 options to buy
@ $26.46, valued at
$119.1k
Disposed/sold 2,000 options to buy
@ $25.52, valued at
$51k
Disposed/sold 8,000 options to buy
@ $39.48, valued at
$315.8k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 106 shares
@ $93.61, valued at
$9.9k
Granted 1,682 shares
@ $93.61, valued at
$157.5k
Granted 135 options to buy
@ $93.61, valued at
$12.6k
Granted 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 04/04/2023 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 39,249 shares
@ $0
Disposed/sold 2,000 shares
@ $0
Disposed/sold 1,437 options to buy
@ $3.36, valued at
$4.8k
Disposed/sold 4,844 options to buy
@ $6.5, valued at
$31.5k
Disposed/sold 9,848 options to buy
@ $6.58, valued at
$64.8k
Disposed/sold 16,536 options to buy
@ $3.27, valued at
$54.1k
Disposed/sold 28,446 options to buy
@ $2.08, valued at
$59.2k
Disposed/sold 5,271 options to buy
@ $8.86, valued at
$46.7k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 59 shares
@ $27.32, valued at
$1.6k
Granted 99 options to buy
@ $27.32, valued at
$2.7k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 4,000 shares
@ $0
Sold 2,542 shares
@ $172.4384, valued at
$438.3k
Sold 970 shares
@ $173.2148, valued at
$168k
Sold 488 shares
@ $174.8196, valued at
$85.3k
Exercised 4,000 options to buy
@ $25.52, valued at
$102.1k
Converted 4,000 options to buy
@ $0 |
|
| 11/10/2020 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 4,000 shares
@ $0
Sold 4,000 shares
@ $150.01, valued at
$600k
Exercised 1,500 options to buy
@ $26.46, valued at
$39.7k
Exercised 2,500 options to buy
@ $26.46, valued at
$66.2k
Converted 4,000 options to buy
@ $0 |
|
| 06/22/2020 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 6,300 options to buy
@ $130.92, valued at
$824.8k
|
|
| 05/11/2020 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 10,257 shares
@ $0
Granted 28,446 options to buy
@ $2.08, valued at
$59.2k
|
|
| 08/20/2019 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 5,399 shares
@ $0
Granted 16,536 options to buy
@ $3.27, valued at
$54.1k
|
|
| 06/13/2019 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 9,000 options to buy
@ $88.75, valued at
$798.8k
|
|
| 06/14/2018 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $39.48, valued at
$315.8k
|
|
| 03/02/2018 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Granted 2,873 shares
@ $0
Granted 9,848 options to buy
@ $6.58, valued at
$64.8k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|